Semuloparin sodium
| Clinical data | |
|---|---|
| Other names | AVE-5026 |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| ECHA InfoCard | 100.110.590 |
| Chemical and physical data | |
| Molar mass | 2000–3000 g/mol (average) |
Semuloparin (INN, USAN) is an experimental antithrombotic being developed by Sanofi-Aventis and belongs to the group of low molecular weight heparins (LMWH).[1] It has completed Phase III clinical trials for the prevention of thromboembolism following various kinds of surgery such as hip replacement,[2] as well as for patients undergoing chemotherapy.[3]
Like bemiparin, semuloparin is classified as an ultra-LMWH because of its low molecular mass of 2000–3000 g/mol on average. (Enoxaparin has 4500 g/mol) These heparins have lower anti-thrombin activity than classical LMWHs and act mainly on factor Xa, reducing the risk of bleeding.[4][5]
References
- ^ Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Rocha E, Pozo-Hernández C, Vargas-Castrillón E (February 2011). "New parenteral anticoagulants in development". Therapeutic Advances in Cardiovascular Disease. 5 (1): 33–59. doi:10.1177/1753944710387808. PMID 21045018. S2CID 36442831.
- ^ Clinical trial number NCT00697099 for "Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery (SAVE-HIP1)" at ClinicalTrials.gov
- ^ Clinical trial number NCT00694382 for "Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy (SAVE-ONCO)" at ClinicalTrials.gov
- ^ Jeske WP, Hoppensteadt D, Gray A, Walenga JM, Cunanan J, Myers L, et al. (October 2011). "A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparin". Thrombosis Research. 128 (4): 361–7. doi:10.1016/j.thromres.2011.03.001. PMID 21458847.
- ^ Statement On A Nonproprietary Name Adopted By The Usan Council: Semuloparin Sodium
 | This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Chemicals that do not have a ChemSpider ID assigned
- ECHA InfoCard ID from Wikidata
- Infobox-drug molecular-weight unexpected-character
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles containing unverified chemical infoboxes
- Heparins
- All stub articles
- Blood and blood forming organ drug stubs